Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Acta Neurologica Scandinavica|July 1, 2016
Predictors of the 10-year direct costs for treating multiple sclerosisM Moccia, R Palladino, R Lanzillo, et al.
European Journal of Neurology|April 21, 2017
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's diseaseM Picillo, R Palladino, P Barone, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|February 26, 2013
Prevalence survey of healthcare-associated infections in the University Hospital Federico II of Naples, ItalyE Montella, W Reis, R Palladino, et al.
Acta Neurologica Scandinavica|October 8, 2014
Uric acid relates to dopamine transporter availability in Parkinson's diseaseM Moccia, S Pappatà, R Erro, et al.
European Review for Medical and Pharmacological Sciences|January 18, 2024
Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
European Review for Medical and Pharmacological Sciences|March 4, 2024
Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
Pageof 2